End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.089 AUD | +9.88% | +23.61% | +50.85% |
01:44am | Percheron Therapeutics Names Chief Medical Advisor | MT |
May. 29 | Percheron Therapeutics Completes Enrollment for Phase Two Muscular Dystrophy Trial; Shares Rise 3% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+50.85% | 48.49M | |
+14.97% | 118B | |
+13.00% | 106B | |
-3.40% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-16.97% | 15.56B | |
+5.62% | 13.63B | |
+28.45% | 12.27B |
- Stock Market
- Equities
- PER Stock
- News Percheron Therapeutics Limited
- Percheron Therapeutics Secures US Patent for Muscular Dystrophy Medicinal Candidate